Difficulty: Medium
Average Score: 64%
Practice
Which of the following patients with neuroblastomas falls into a 'high risk' pretreatment group?(When not mentioned, assume molecular tests are negative)
Correct answer
A
Rationale
MYCN amplification indicates high risk despite non-metastatic status.